Overweight Clinical Trial
— TeleSOFTOfficial title:
Treatment of Overweight in Children on Distance. A Comparison Between Consultations on the Hospital With Video-Consultations on Distance
Verified date | April 2024 |
Source | Skane University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The present study is a public health project with the aim to treat overweight in children 9-11 years of age. After the first consultation the children are randomized to either continue the treatment at The Child Obesity Clinic, Child Department or to have the following 2-3 consultations on distance with Lync. Last visit for all children is on the Child Obesity Clinic after approximately 12 months. Follow up after at least 1 years will be performed.
Status | Active, not recruiting |
Enrollment | 94 |
Est. completion date | January 31, 2025 |
Est. primary completion date | December 20, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Years to 12 Years |
Eligibility | Inclusion Criteria: - Children with overweight and not obese according to the definitions developed by Cole et al (4). It implies that we include children with the following age specific BMI Inclusion criteria - 9 years = AGE < 9 years, 6 months AND 19,0< BMI<23,0 - 9 years, 6 months => AGE < 10 Years AND 19,5 <BMI<23,5 - 10 years = AGE < 10 years, 6 months AND 20,0<BMI<24,0 - 10 years, 6 months=>AGE< 11 years AND 20,5<BMI<24,5 - 11 years = AGE < 11 years, 6 months AND 21,0<BMI<25,5 - 11 years, 6 months =>AGE<12 years AND 21,5<BMI<25,5 Exclusion Criteria: - Children and his/her parents not able to communicate in Swedish. - Children with monogenic obesity - Present less than 80% at school in the latest school year. - No foster care for the child or his/her brothers or sisters |
Country | Name | City | State |
---|---|---|---|
Sweden | Barnmedicin | Malmö | Scania |
Lead Sponsor | Collaborator |
---|---|
Skane University Hospital | Lund University |
Sweden,
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000 May 6;320(7244):1240-3. doi: 10.1136/bmj.320.7244.1240. — View Citation
Flodmark CE, Ohlsson T, Ryden O, Sveger T. Prevention of progression to severe obesity in a group of obese schoolchildren treated with family therapy. Pediatrics. 1993 May;91(5):880-4. — View Citation
Nowicka P, Flodmark CE. Family therapy as a model for treating childhood obesity: useful tools for clinicians. Clin Child Psychol Psychiatry. 2011 Jan;16(1):129-45. doi: 10.1177/1359104509355020. Epub 2010 Jul 22. — View Citation
Nowicka P, Pietrobelli A, Flodmark CE. Low-intensity family therapy intervention is useful in a clinical setting to treat obese and extremely obese children. Int J Pediatr Obes. 2007;2(4):211-7. doi: 10.1080/17477160701379810. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body mass index standard deviation score (BMI Z-score) during treatment of overweight | Body weight measured by Tanita device | Change from Baseline in body weight at an average of 12 months | |
Secondary | Change in fat percent measured by TANITA | TANITA measures fat percent via bioimpedance | Change from Baseline in fat percent at an average of 12 months | |
Secondary | Change in fat distribution measured by abdominal height (F-indicator) | F-indicator uses a laser beam to measure the abdominal height | Change from Baseline in fat distribution at an average of 12 months | |
Secondary | Change in fat distribution measured by waist circumference | Measured using a measurement tape | Change from Baseline in waist circumference at an average of 12 months | |
Secondary | Change in KIDSCREEN-index | Use a validated questionnaire | Change from Baseline in Kidscreen index at an average of 12 months | |
Secondary | Change in physical activity measured by Moves application to smartphone | Measured through an app on a smart phone. | Change from Baseline in physical activity at an average of 2, 4, 6, 8, 12 months | |
Secondary | Change child's metabolic health (Blood pressure) | Standardized laboratory tests will be performed | Change from Baseline in metabolic health at an average of 12 months | |
Secondary | Change child's metabolic health (LDL-cholesterol) | Standardized laboratory tests will be performed | Change from Baseline in metabolic health at an average of 12 months | |
Secondary | Change child's metabolic health (HDL-cholesterol) | Standardized laboratory tests will be performed | Change from Baseline in metabolic health at an average of 12 months | |
Secondary | Change child's metabolic health (triglycerides) | Standardized laboratory tests will be performed | Change from Baseline in metabolic health at an average of 12 months | |
Secondary | Change child's metabolic health (HbA1c) | Standardized laboratory tests will be performed | Change from Baseline in metabolic health at an average of 12 months | |
Secondary | Change child's metabolic health (F-blood glucose) | Standardized laboratory tests will be performed | Change from Baseline in metabolic health at an average of 12 months | |
Secondary | Change child's metabolic health (f-insulin) | Standardized laboratory tests will be performed | Change from Baseline in metabolic health at an average of 12 months | |
Secondary | Change child's metabolic health (ccK-18) | Standardized laboratory tests will be performed | Change from Baseline in metabolic health at an average of 12 months | |
Secondary | Change child's metabolic health (ALAT) | Standardized laboratory tests will be performed | Change from Baseline in metabolic health at an average of 12 months | |
Secondary | Change in dietary habits | Normal procedure at The Child Obesity Unit using a questionnaire | Change from Baseline in dietary habits at an average of 12 months | |
Secondary | Change in Outcome Rating Scale and Session Rating Scale | Measured psychological Health in general by four questions combined to a general score on a Visual analogue scale | Change from Baseline in Outcome Rating Scale at an average of 2, 4, 6, 8, 12 months | |
Secondary | Change in Session Rating Scale | Measured assessment of the consultation by visual analogue scale | Change from Baseline in Session Rating scale at an average of 2, 4, 6, 8, 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Completed |
NCT03097237 -
High Fiber Rye Foods for Weight and Body Fat Reduction
|
N/A | |
Terminated |
NCT02796144 -
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
|
Phase 4 |